相关实验视频

Updated: May 31, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

心血管医学中的CRISPR-Cas9:释放治疗的新潜力

Klaudia Bonowicz^1,2, Dominika Jerka¹, Klaudia Piekarska¹

¹Department of Histology and Embryology and Vascular Biology Student Research Club, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-092 Bydgoszcz, Poland.

|January 24, 2025

概括

克里斯普尔-Cas9基因编辑通过纠正基因突变为治疗心血管疾病 (CVD) 提供了一个有前途的方法. 虽然存在诸如分娩和伦理等挑战,但这项技术可能会彻底改变心血管医学.

科学领域:

遗传学遗传学是一个
分子生物学分子生物学
心血管医学心血管医学

背景情况:

心血管疾病 (CVD) 是一个主要的全球健康问题,目前的治疗方法往往控制症状,而不是潜在的遗传原因.
克里斯普尔-Cas9基因编辑技术为直接解决引起疾病的突变提供了一种新的治疗策略.
现有的心血管疾病治疗方法无法解决这些疾病的遗传基础.

研究的目的:

检查CRISPR-Cas9技术在治疗各种心血管疾病 (CVD) 中的潜在应用.
探索CRISPR-Cas9的进展,包括其在心血管疾病的线粒体基因组编辑中的应用.
讨论与CRISPR-Cas9对心血管疾病的基因编辑相关的挑战和伦理考虑.

主要方法:

审查CRISPR-Cas9技术在纠正与心血管疾病相关的单基因突变方面的能力.
对最近的发展进行分析,包括用于心血管应用的线粒体基因组编辑.
检查挑战,如非目标效应,交付方法和伦理影响.

主要成果:

在纠正致病突变方面,CRISPR-Cas9表现出高精度和高效率.
该技术的范围已经扩大到包括线粒体基因组编辑,这对于心血管疾病至关重要.
仍然存在重大障碍,包括非目标突变,传递系统限制和道德问题.

结论:

克里斯普尔-Cas9在治疗遗传驱动的心血管疾病方面具有变革性的潜力.
需要进一步的研究来提高临床翻译的准确性,传递性,安全性和有效性.
克服当前的挑战可能会开启精确心血管医学的新时代.

关键词:

克里斯普尔-Cas9是什么意思心血管疾病 (CVD) 是一种心血管疾病.基因治疗的基因疗法线粒体基因组编辑

更多相关视频

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts

Published on: September 13, 2022

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...